...
首页> 外文期刊>Biotechnology and Bioengineering >Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring
【24h】

Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring

机译:纳米级整合单细胞生物制片发现过程使用Optof流体操纵和监测

获取原文
获取原文并翻译 | 示例

摘要

The new and rapid advancement in the complexity of biologics drug discovery has been driven by a deeper understanding of biological systems combined with innovative new therapeutic modalities, paving the way to breakthrough therapies for previously intractable diseases. These exciting times in biomedical innovation require the development of novel technologies to facilitate the sophisticated, multifaceted, high-paced workflows necessary to support modern large molecule drug discovery. A high-level aspiration is a true integration of "lab-on-a-chip" methods that vastly miniaturize cellulmical experiments could transform the speed, cost, and success of multiple workstreams in biologics development. Several microscale bioprocess technologies have been established that incrementally address these needs, yet each is inflexibly designed for a very specific process thus limiting an integrated holistic application. A more fully integrated nanoscale approach that incorporates manipulation, culture, analytics, and traceable digital record keeping of thousands of single cells in a relevant nanoenvironment would be a transformative technology capable of keeping pace with today's rapid and complex drug discovery demands. The recent advent of optical manipulation of cells using light-induced electrokinetics with micro- and nanoscale cell culture is poised to revolutionize both fundamental and applied biological research. In this review, we summarize the current state of the art for optical manipulation techniques and discuss emerging biological applications of this technology. In particular, we focus on promising prospects for drug discovery workflows, including antibody discovery, bioassay development, antibody engineering, and cell line development, which are enabled by the automation and industrialization of an integrated optoelectronic single-cell manipulation and culture platform. Continued development of such platforms will be well positioned to overcome many of the challen
机译:生物制剂药物发现复杂性的新的和快速进步是对生物系统的更深入的了解,与创新的新治疗方式相结合,铺平了以前顽固的疾病的突破性疗法。这些令人兴奋的生物医学创新时期需要开发新颖的技术,以促进支持现代大分子药物发现所必需的精密,多方面的高节奏工作流程。高级别的愿望是“实验室内芯片”方法的真正集成,即大型小型化纤维素实验可以改变生物制剂发育中多个工作流的速度,成本和成功。已经建立了几种微型生物过程技术,逐步解决了这些需求,但每个都是针对非常具体的过程设计的,因此限制了集成的整体应用。一种更完整的纳米级方法,包括在相关纳米环境中的操作,培养,分析和可追踪数字记录成千上万的单个细胞将是一种能够与今天的快速和复杂的药物发现需求保持同步的变化技术。最近利用具有微型和纳米级细胞培养的光诱导电动电动细胞的细胞光学操纵的最近出现是彻底改变基本和应用的生物研究。在本文中,我们总结了光学操作技术的现有技术,并讨论了这种技术的新兴生物学应用。特别是,我们专注于对药物发现工作流程的有希望的前景,包括抗体发现,生物测定型发育,抗体工程和细胞系发育,通过集成光电单细胞操纵和培养平台的自动化和工业化实现。继续发展这些平台将得到很好的定位,以克服许多危险

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号